News & Resources

Press Release

Printer Friendly Version View printer-friendly version
<< Back
Orexigen Therapeutics to Provide Business Update and Discuss Fourth Quarter and Year End 2016 Financial Results on March 28, 2017

SAN DIEGO, March 7, 2017 /PRNewswire/ -- Orexigen Therapeutics, Inc. (NASDAQ: OREX) will announce corporate and financial results for the fourth quarter and full year 2016 on Tuesday, March 28th before the market opens. Following the announcement, Orexigen will provide a business update and discuss the financial results in a live webcast and conference call at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time).

The live call may be accessed by phone by calling (888) 771-4371 (domestic) or (847) 585-4405 (international), participant code 44520315. The webcast can be accessed live on the "Investors" section of the company's website at www.orexigen.com, and will be archived for 14 days following the call.

Orexigen Contact:

Jason Keyes
Chief Financial Officer
Orexigen Therapeutics, Inc.
+1-858-875-8600
jkeyes@orexigen.com

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/orexigen-therapeutics-to-provide-business-update-and-discuss-fourth-quarter-and-year-end-2016-financial-results-on-march-28-2017-300419969.html

SOURCE Orexigen Therapeutics, Inc.